ADAMS Street Partners LLC, 10% Owner at Fusion Pharmaceuticals Inc. (FUSN), sold 3,800 shares at $12.32 ($47K) on 2020-12-24, disclosed to the SEC on 2020-12-29.
Open-market sale of $47k FUSN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.32 | 455 | $6K | 12.0% |
| 2 | $12.32 | 469 | $6K | 12.3% |
| 3 | $12.32 | 611 | $8K | 16.1% |
| 4 | $12.32 | 681 | $8K | 17.9% |
| 5 | $12.32 | 1,584 | $20K | 41.7% |
| Total | $12.32 avg | 3,800 |
| $47K |
| 100% |
| Filing → |
| FUSN | SELL | 2020-12-28 | $57K | — | Filing → |
| APTX | BUY | 2020-01-14 | $3.0M | — | Filing → |
| APTX | BUY | 2018-06-26 | $2.4M | — | Filing → |